Bristol-Myers Squibb
BMY
#198
Rank
$113.68 B
Marketcap
$55.67
Share price
-0.87%
Change (1 day)
17.08%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): $3.56

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is $3.56. In 2025 the company made an earnings per share (EPS) of $3.46 an increase over its 2024 EPS that were of -$4.42.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$3.562.89%
2025$3.46-178.28%
2024-$4.42-213.92%
2023$3.8830.2%
2022$2.98-6.04%
2021$3.17-179.29%
2020-$4.00-281.37%
2019$2.21-27.21%
2018$3.03
2016$2.67175.26%
2015$0.97-19.83%
2014$1.21-22.44%
2013$1.5634.48%
2012$1.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$8.74 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$7.02 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$1.31-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$2.06-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$28.23 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$14.48 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$2.56-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$9.35 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$3.56-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$6.95 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK